Menu Search
Equities

Shanghai HeartCare Medical Technology Corp Ltd

6609:HKG.HS

Shanghai HeartCare Medical Technology Corp Ltd

Actions
  • Price (HKD)15.10
  • Today's Change0.02 / 0.13%
  • Shares traded700.00
  • 1 Year change-50.81%
  • Beta--
Data delayed at least 15 minutes, as of Jul 26 2024 07:14 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Shanghai HeartCare Medical Technology Corp Ltd is a China-based company engaged in the research and development of innovative neuro-interventional medical device. The Company's product portfolio includes both neuro-interventional and cardiac medical devices, and its main products are CaptorTM thrombectomy device (Captor) and left atrial appendage occluder. The Company's product portfolio extends from the treatment and prevention of ischemic stroke, including acute ischemic stroke and intracranial stenosis to the treatment of hemorrhagic stroke. The Company's other products include the balloon guiding catheter, the ExtraFlex distal access catheter and SupSelek microcatheter. The Company distributes its products within the domestic market.

  • Revenue in HKD (TTM)250.83m
  • Net income in HKD-101.49m
  • Incorporated2016
  • Employees368.00
  • Location
    Shanghai HeartCare Medical Technology Corp Ltd1F and 3F, Building 38No. 356, Zhengbo Road, Lingang New AreaPilot Free Trade ZoneSHANGHAI 201201ChinaCHN
  • Phone+86 2 158975055
  • Websitehttp://www.heartcare.com.cn/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.